Rankings
▼
Calendar
PRAX (Praxis Precision Medicines, Inc.) Stock Financials & Earnings | Market Cap Arena
PRAX
Praxis Precision Medicines, Inc.
Mkt Cap
$7B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$0
Net Income (TTM)
-$303M
EPS (TTM)
-$13.46
Free Cash Flow (TTM)
-$249M
Gross Margin
—
Op. Margin
—
Net Margin
—
FCF Margin
—
P/S Ratio (TTM)
—
P/E Ratio (TTM)
—
YoY Rev Growth
-100.0%
Employees
—
Earnings Reports
▶
Q4 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$683K
-$25M
-$38M
Q2 23
$781K
-$25M
-$35M
Q3 23
$468K
-$17M
-$26M
Q4 23
$515K
-$18M
-$28M
Q1 24
$431K
-$27M
-$42M
Q2 24
$357K
-$27M
-$37M
Q3 24
$302K
-$42M
-$57M
Q4 24
$7M
-$49M
-$64M
Q1 25
$0
-$61M
-$75M
Q2 25
$0
-$63M
-$76M
Q3 25
$0
-$66M
-$78M
Q4 25
$0
-$28K
-$97M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
9955.5x
—
Q2 23
4644.5x
—
Q3 23
3519.4x
—
Q4 23
2778.7x
—
Q1 24
3097.8x
—
Q2 24
3839.4x
—
Q3 24
4236.5x
—
Q4 24
795.0x
—
Q1 25
837.2x
—
Q2 25
875.7x
—
Q3 25
911.1x
—
Q4 25
—
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$33M
-$33M
Q2 23
-$31M
-$31M
Q3 23
-$23M
-$23M
Q4 23
-$24M
-$24M
Q1 24
-$21M
-$21M
Q2 24
-$27M
-$27M
Q3 24
-$28M
-$28M
Q4 24
-$56M
-$56M
Q1 25
-$53M
-$53M
Q2 25
-$55M
-$55M
Q3 25
-$65M
-$65M
Q4 25
-$77M
-$77M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$0
Q2 23
$0
Q3 23
$0
Q4 23
$50K
Q1 24
$0
Q2 24
$0
Q3 24
$0
Q4 24
$0
Q1 25
$0
Q2 25
$120K
Q3 25
$0
Q4 25
$0
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
—
-43.7%
Q2 23
—
-40.8%
Q3 23
—
-41.3%
Q4 23
—
-31.7%
Q1 24
-36.9%
+9.1%
Q2 24
-54.3%
+5.9%
Q3 24
-35.5%
+119.9%
Q4 24
+1349.1%
+152.2%
Q1 25
-100.0%
+76.6%
Q2 25
-100.0%
+101.0%
Q3 25
-100.0%
+37.1%
Q4 25
-100.0%
+35.9%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$0
0.0%
Q2 23
$0
0.0%
Q3 23
$0
0.0%
Q4 23
$6M
1111.8%
Q1 24
$14M
3358.5%
Q2 24
$6M
1646.5%
Q3 24
$12M
4116.6%
Q4 24
$9M
114.9%
Q1 25
$9M
—
Q2 25
$8M
—
Q3 25
$7M
—
Q4 25
$0
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q1 23
$26M
$13M
Q2 23
$26M
$10M
Q3 23
$17M
$9M
Q4 23
$18M
$10M
Q1 24
$27M
$15M
Q2 24
$27M
$11M
Q3 24
$42M
$15M
Q4 24
$56M
$15M
Q1 25
$61M
$14M
Q2 25
$63M
$13M
Q3 25
$66M
$13M
Q4 25
$78M
$20M
marketcaparena.com
Revenue Segments
License
Quarter
License
Q1 23
$700K
Q2 23
$800K
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$81M
$5M
$86M
Q2 23
$124M
$0
$124M
Q3 23
$101M
$0
$101M
Q4 23
$81M
$0
$81M
Q1 24
$152M
$55M
$207M
Q2 24
$145M
$207M
$352M
Q3 24
$169M
$188M
$357M
Q4 24
$215M
$177M
$393M
Q1 25
$166M
$162M
$328M
Q2 25
$157M
$144M
$301M
Q3 25
$150M
$118M
$267M
Q4 25
$357M
$242M
$599M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
4M
+11.6%
Q2 23
5M
+31.3%
Q3 23
9M
+94.4%
Q4 23
9M
+0.2%
Q1 24
14M
+53.5%
Q2 24
19M
+35.4%
Q3 24
19M
+0.3%
Q4 24
20M
+5.8%
Q1 25
21M
+5.4%
Q2 25
21M
+2.0%
Q3 25
22M
+2.3%
Q4 25
23M
+2.4%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 18
—
—
FY 19
—
—
FY 20
$0
67
FY 21
$0
139
FY 22
$0
109
FY 23
$30K
82
FY 24
$74K
116
FY 25
$0
168
marketcaparena.com